Product Details

Doxorubicin HCl for Injection BP is manufactured to strict BP-standard specifications for use in cancer chemotherapy. It is prescribed for the treatment of several malignancies.

The injection combines:

• Doxorubicin Hydrochloride — an anthracycline antineoplastic antibiotic that intercalates DNA and inhibits topoisomerase II, blocking cancer cell replication and inducing cell death

Doxorubicin HCl for Injection BP is indicated in the treatment of breast cancer, lymphomas, leukemias, and several other solid tumors. As a result, it is administered under close oncology supervision, typically in hospital infusion units and specialized cancer care centers.

Key Features:

• Manufactured to BP-standard compliance for consistent quality
• Lyophilized sterile powder ensures stability before reconstitution
• Accurate potency per vial supports precise dosing in chemotherapy protocols
• Supplied with Sterile Water for Injection BP for convenient reconstitution
• Single Dose Vial format minimizes contamination risk
• Suitable for hospital pharmacies, oncology centers, and institutional supply